Efficacy of the Cation Exchange Resin, Sodium Polystyrene Sulfonate, to Decrease Iron Absorption

REFERENCES

• Litovitz T L, Manoguerra A. Comparison of pediatric hazards: An analysis of 3.8 million exposure incidents. A report from the American Association of Poison Control Centers. Pediatrics 1992; 89: 999–1006
   PubMed Web of Science ®Google Scholar
• Iron containing supplements and drugs: Label warning statement and packaging requirements: Final rule. Federal Register 1997; 62: 2217–2250
   Google Scholar
• Greffner M E, Opas L M. Phosphate poisoning complicating treatment for iron ingestion. Am J Dis Child 1980; 134: 509–510
   PubMedGoogle Scholar
• Czajka P A, Konrad J D, Duffy J P. Iron Poisoning: An in vitro comparison of bicarbonate and phosphate lavage solutions. J Pediatr 1981; 98: 491–494
   PubMed Web of Science ®Google Scholar
• Bachrach L, Correa A, Levin R, et al. Iron poisoning and complications of hypertonic phosphate lavage therapy. J Pediatr 1979; 94: 147–149
   PubMed Web of Science ®Google Scholar
• Tenenbien M. Whole bowel irrigation in iron poisoning. J Pediatr 1987; 111: 142–145
   PubMed Web of Science ®Google Scholar
• O'Connor T A, Gruner B A, Gehrke J C, Watling S M, Gehrke C W. In vitro binding of iron with the cation exchange resin sodium polystyrene sulfonate. Ann Emerg Med 1996; 28: 504–507
   PubMed Web of Science ®Google Scholar
• Watling S M, Gehrke J C, Gehrke C W, Zumwalt R, Pribble J. In vitro binding of lithium using the cation exchange resin, sodium polystyrene sulfonate. Am J Emerg Med 1995; 13: 294–296
   PubMed Web of Science ®Google Scholar
• Gehrke J C, Watling S M, Gehrke C W, Zumwalt R. In vivo binding of lithium using the cation exchange resin, sodium polystyrene sulfonate. Am J Emerg Med 1996; 14: 37–38
   PubMed Web of Science ®Google Scholar
• Belanger D R, Tierney M G, Dickinson G. Effect of sodium polystyrene sulfonate on lithium bioavailability. Ann Emerg Med 1992; 21: 1312–1315
   PubMed Web of Science ®Google Scholar
• Roberge R J, Martin T G, Scheneider S M. Use of sodium polystyrene sulfonate in a lithium overdose. Ann Emerg Med 1993; 22: 1911–1915
   PubMed Web of Science ®Google Scholar
• Non-compartmental analysis. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, J Gabrielson, D Weiner. 2nd Ed., Swedish Pharmaceutical Society, Swedish Pharmaceutical Press, StockholmSweden 1997
   Google Scholar
• Walker S E, Paton T W, Cowan D H, Manuel M A, Dranitsaris G. Bioavailibility of iron in ferrous sulfate preparations in healthy volunteers. Can Med Assoc J 1989; 141: 543–547
   PubMed Web of Science ®Google Scholar
• Decker W J, Combs H F, Corby D G. Adsorption of drugs and poisons by activated charcoal. Toxicol Appl Pharmacol 1968; 13: 454–460
   PubMed Web of Science ®Google Scholar
• Oderda G M, Klein-Schwartz W, Insley B M. In vitro study of boric acid and activated charcoal. J Toxicol Clin Toxicol 1987; 25: 13–19
   PubMed Web of Science ®Google Scholar
• Favin F D, Klein-Schwartz W, Oderda G M, Rose S R. In vitro study of lithium carbonate adsorption by activated charcoal. J Toxicol Clin Toxicol 1988; 26: 443–450
   PubMed Web of Science ®Google Scholar
• Picchioni A L. Activated charcoal, a neglected antidote. Ped Clin N Am 1970; 17: 535–543
   PubMed Web of Science ®Google Scholar
• Andersen A H. Experimental studies on the pharmacology of activated charcoal. I. Adsorption power of charcoal in aqueous solutions. Acta Pharmacol 1946; 2: 69–78
   Google Scholar
• North D S, Thompson J D, Peterson C D. Effect of activated charcoal on ethanol blood levels in dogs. Am J Hosp Pharm 1981; 38: 864–866
   PubMedGoogle Scholar
• Jackson T W, Ling L J, Washington V. The effect of oral deferoxamine on iron absorption in humans. J Toxicol Clin Toxicol 1995; 33: 325–329
   PubMed Web of Science ®Google Scholar
• Wallace K L, Curry S C, LoVecchio F, Raschke R A. Effects of magnesium hydroxide on iron absorption following simulated mild iron overdose in human subjects. Academic Emerg Med 1998; 5: 961–965
   PubMed Web of Science ®Google Scholar
• Gomez H F, McClafferty H H, Flory D, Brent J, Dart R C. Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry. Ann Emerg Med 1997; 30: 587–592
   PubMed Web of Science ®Google Scholar
• Frohnert P P, Johnson W J, Mueller G J, Tauxe W N, McCall J T. Resin treatment of hyperkalemia. II. Clinical experience with a cation exchange resin (calcium cycle). J Lab Clin Med 1968; 71: 840–846
   PubMedGoogle Scholar
• Linakis J G, Lacouture P G, Woolf A. Iron absorption from chewable vitamins iron versus iron tablets: Implications for toxicity. Ped Emerg Care 1992; 8: 321–324
   PubMed Web of Science ®Google Scholar
• Ling L J, Hornfeldt C S, Winter J P. Absorption of iron after experimental overdose of chewable vitamins. Am J Emerg Med 1991; 9: 24–26
   PubMed Web of Science ®Google Scholar
• Burkhart K K, Kulig K W, Hammond K B, et al. The rise in the total iron binding capacity after iron overdose. Ann Emerg Med 1991; 20: 532–535
   PubMed Web of Science ®Google Scholar
• Chiou W L. Ferrous sulfate bioavailability monograph. J Am Pharm Assoc 1977; 17: 377–380
   PubMedGoogle Scholar